[Changes of therapeutic dogma in obstructive lung diseases].
The changes in understanding of the pathogenesis of obstructive diseases of the respiratory tract are responsible for therapeutic strategy. In the paper some discussible current problems is this field have been presented.
Płusa
Tadeusz
T
Wojskowy Instytut Medyczny, Klinika Chorób Wewnetrznych, Pneumonologii i Alergologii CSK MON w Warszawie.
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D004357:Drug Synergism; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*
D000318:Adrenergic beta-Agonists; D000893:Anti-Inflammatory Agents